Voya Financial Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History

Voya Financial Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $271,458 - $304,820	-3,595 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $9,266 - $11,245	124 Added 3.57%	3,595 $269,000
Q4 2020 Mar 05, 2021	SELL	$72.61 - $90.2 $5,082 - $6,314	-70 Reduced 1.98%	3,471 $302,000
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $10,421 - $18,999	145 Added 4.27%	3,541 $269,000
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $3,579 - $5,589	45 Added 1.34%	3,396 $415,000
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $239,160 - $324,544	3,351 New	3,351 $276,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.